[Kawasaki disease (Kawasaki syndrome)]

Nihon Rinsho. 2005 May:63 Suppl 5:391-9.

[Article in Japanese]

Authors

Takuro Ohno¹, Kenji Furuno, Kazuyuki Ikeda, Toshiro Hara

Affiliation

¹ Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University.

PMID: 15954382

No abstract available

Publication types

Review

MeSH terms

Aspirin / administration & dosage
Bacterial Proteins
Bacterial Toxins
Capillary Permeability
Chemokine CCL2 / genetics
Cytokines
Enterotoxins
Exotoxins
Heat-Shock Proteins
Hepatocyte Growth Factor
Humans
Immunoglobulins, Intravenous / administration & dosage
Leukocytes, Mononuclear / immunology
Membrane Proteins
Mucocutaneous Lymph Node Syndrome* / diagnosis
Mucocutaneous Lymph Node Syndrome* / etiology
Mucocutaneous Lymph Node Syndrome* / therapy
Peptidyl-Dipeptidase A / genetics
Polymorphism, Genetic
Prognosis
Receptors, Vascular Endothelial Growth Factor
Superantigens
Vascular Endothelial Growth Factor A

Substances

Bacterial Proteins
Bacterial Toxins
CCL2 protein, human
Chemokine CCL2
Cytokines
Enterotoxins
Exotoxins
Heat-Shock Proteins
Immunoglobulins, Intravenous
Membrane Proteins
SpeA protein, Streptococcus pyogenes
Superantigens
Vascular Endothelial Growth Factor A
enterotoxin F, Staphylococcal
Hepatocyte Growth Factor
Receptors, Vascular Endothelial Growth Factor
Peptidyl-Dipeptidase A
Aspirin